R Squared LTD Intellia Therapeutics, Inc. Transaction History

R Squared LTD

  • $232 Billion
  • Q3 2025

A detailed history of R Squared LTD transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, R Squared LTD holds 10,782 shares of NTLA stock, worth $93,803. This represents 0.08% of its overall portfolio holdings.

Number of Shares
10,782
Holding current value
$93,803
% of portfolio
0.08%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
BUY
$9.88 - $17.76 $106,526 - $191,488
10,782 New
10,782 $186 Million
Q4 2024

Jan 22, 2025
BUY
$11.41 - $21.09 $18,598 - $34,376
1,630 New
1,630 $19 Million

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $661M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track R Squared LTD Portfolio

Follow R Squared LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of R Squared LTD, based on Form 13F filings with the SEC.

News

Stay updated on R Squared LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email